ClinicalTrials.govpublic full text
Daunorubicin, Cytarabine, and Midostaurin in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia
leukemia, adult acute basophilic leukemia, adult acute eosinophilic leukemia, adult acute lymphoblastic leukemia, adult acute megakaryoblastic leukemia (m7), adult acute minimally differentiated myeloid leukemia (m0), adult acute monoblastic leukemia (m5a), adult acute monocytic leukemia (m5b), adult acute myeloblastic leukemia with maturation (m2), adult acute myeloblastic leukemia without maturation (m1), adult acute myeloid leukemia with 11q23 (mll) abnormalities, adult acute myeloid leukemia with inv(16)(p13;q22)
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Record · ID 918113
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.